[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"autologous-serum-eye-drops\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:autologous-serum-eye-drops":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100615675","autologous-serum-eye-drops-in-dry-eye-syndrome-100615675",false,"NCT07295691","Autologous Serum Eye Drops in Dry Eye Syndrome","Autologous Serum Eye Drops in Dry Eye Syndrome: Clinical Efficacy and Safety Evaluation","Inclusion Criteria:\n\n* Children aged less than 18 years.\n* Both sexes.\n* Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.\n\nExclusion Criteria:\n\n* Active ocular infection.\n* Recent ocular surgery.\n* Systemic immunosuppressive therapy.\n* History of allergy to blood-derived products.","ALL","18 Years",{"count":19,"type":20},70,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.",[26,27],"Autologous Serum Eye Drops","Dry Eye Syndrome","RECRUITING","2025-12-06",{"date":31,"type":32},"2025-12-22","ACTUAL",{"date":34,"type":32},"2025-09-01",{"date":36,"type":20},"2025-12-31",{"name":38,"class":39},"The General Authority for Teaching Hospitals and Institutes","NETWORK"]